4YHF
Bruton's tyrosine kinase in complex with a t-butyl cyanoacrylamide inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 8.2.1 |
Synchrotron site | ALS |
Beamline | 8.2.1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2011-12-01 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 1.000 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 43.770, 77.090, 88.030 |
Unit cell angles | 90.00, 96.43, 90.00 |
Refinement procedure
Resolution | 38.550 - 2.200 |
R-factor | 0.1762 |
Rwork | 0.174 |
R-free | 0.20790 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3gen |
RMSD bond length | 0.004 |
RMSD bond angle | 0.848 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | PHENIX ((phenix.refine: 1.8.2_1309)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 38.550 | 2.280 |
High resolution limit [Å] | 2.200 | 2.200 |
Number of reflections | 29610 | |
<I/σ(I)> | 11.8 | |
Completeness [%] | 100.0 | 100 |
Redundancy | 4.3 | 4.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 293 | 0.1 M MES pH 6.5, 0.2 M (NH4)SO4, and 30% (w/v) PEG 5000 MME |